UP!

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2019 2019-11-05 0.00 -0.10
Q2 2019 2019-08-06 0.00 -0.02
Q1 2019 2019-05-02 0.00 -0.14
Q4 2018 2019-03-08 0.00 -0.13
Q3 2018 2018-11-01 0.00 -0.15
Q2 2018 2018-08-01 0.00 -0.15
Q1 2018 2018-05-02 0.00 -0.17
Q4 2017 2018-03-07 0.00 -0.15
Q3 2017 2017-11-01 0.00 -0.13
Q2 2017 2017-08-02 0.00 -0.19

Ratings

2016-07-01 Initiated Coverage Roth Capital Buy to Buy
2016-05-09 Reiterated Rating Brean Capital Buy $13.00 to $7.00
2016-05-08 Reiterated Rating FBR & Co. Buy
2016-05-08 Reiterated Rating FBR & Co Buy
2016-04-18 Reiterated Rating FBR & Co. Buy
2016-03-15 Reiterated Rating FBR & Co. Outperform $16.00
2016-03-10 Reiterated Rating Brean Capital Buy $13.00
2016-02-04 Reiterated Rating Brean Capital Buy $13.00
2016-01-07 Reiterated Rating Roth Capital Buy $15.00
2016-01-07 Reiterated Rating Brean Capital Buy $13.00
2015-11-17 Lower Price Target JMP Securities Market Outperform $10.00 to $6.00
2015-11-05 Lower Price Target Stifel Nicolaus Buy $11.00 to $9.00
2015-10-30 Reiterated Rating FBR & Co. Outperform
2015-09-25 Reiterated Rating JMP Securities Outperform $14.00
2015-09-25 Reiterated Rating Brean Capital Buy $13.00
2015-09-24 Reiterated Rating Piper Jaffray Hold $5.00
2015-09-24 Reiterated Rating Roth Capital Buy $15.00
2015-09-24 Reiterated Rating Piper Jaffray Cos. Hold $5.00
2015-09-22 Initiated Coverage HC Wainwright Buy $15.00
2015-09-22 Initiated Coverage HC Wainright Buy
2015-07-01 Reiterated Rating Brean Capital Buy $13.00
2015-06-12 Reiterated Rating Brean Capital Buy $13.00
2015-04-27 Initiated Coverage Brean Capital Buy $13.00
2015-03-17 Initiated Coverage Roth Capital Buy $15.00
2015-03-12 Lower Price Target Stifel Nicolaus Buy $13.00 to $11.00
2015-03-06 Set Price Target MLV & Co. Buy $16.00
2015-01-09 Lower Price Target Roth Capital Buy $19.00 to $12.00
2015-01-09 Downgrade Piper Jaffray Overweight to Neutral
2015-01-06 Set Price Target MLV & Co. Buy $16.00
2014-10-21 Initiated Coverage MLV & Co. Buy $16.00
2014-08-14 Reiterated Stifel Buy $14 to $13
2014-08-14 Lower Price Target Stifel Nicolaus Buy $14.00 to $13.00
2014-06-13 Initiated Coverage Roth Capital Buy $19.00
2014-03-28 Lower Price Target Stifel Nicolaus $16.00 to $14.00
2014-03-07 Initiated Coverage Roth Capital Buy
2013-11-15 Reiterated Rating Stifel Nicolaus Buy $16.00 to $13.00
2016-07-01 Initiated Coverage Roth Capital Buy to Buy
2016-05-09 Reiterated Rating Brean Capital Buy $13.00 to $7.00
2016-05-08 Reiterated Rating FBR & Co. Buy
2016-05-08 Reiterated Rating FBR & Co Buy
2016-04-18 Reiterated Rating FBR & Co. Buy

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In CNAT 0 funds of 2186 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks
ADVENT VENTURE PARTNERS LLP 13.83%  (2166836) CNAT /
Malik Shahzad 13.83%  (2166836) AGEN / CNAT / VSAR /
COOPERATIVE GILDE HEALTHCARE II U.A. 9.50%  (1487320) CNAT /
Perret Marc Olivier 9.50%  (1487320) CNAT /
Scopa James Paul 7.61%  (1192080) CNAT /
MPM BioVentures IV QP LP 7.61%  (1192080) CNAT / EPZM /
EVNIN LUKE 7.61%  (1192080) CNAT / EPRS / EPZM / ETRM / KBIO / PCRX / PIP / RDUS /
LACASSE LOUIS P 5.17%  (809887) CNAT / TGEN /
Cashion Charles SVP, Finance, CFO and Sec. 0.27%  (42424) CNAT / NBY /
Mento Steven J President, CEO & Director 0.23%  (36363) CNAT / SGMO /
RIPLEY DANIEL L. SVP, Bus Dev, P&A Mgmt 0.19%  (29280) CNAT /
HALE DAVID F 0.15%  (24242) CNAT /
Spada Alfred P. SVP, R&D and CSO 0.08%  (12121) CNAT /
KLINGENSTEIN PAUL H 0.06%  (8731) ANAC / CLVS / CNAT / ETRM /
Smith Edward F III SVP, Reg Affairs and QA 0.03%  (4461) CNAT /
KISNER DANIEL L 0.02%  (3145) CNAT / DVAX / LPTN / TKMR /

Comments